Gene · 23765
Papers3,930
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,930
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Relapse of Psoriasis: Mechanisms and Mysteries. | JID Innov | 2022 | 35601055 | PubTator, text mining | PubMed |
| Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis. | Dermatol Ther (Heidelb) | 2022 | 35596901 | PubTator, text mining | PubMed |
| Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques. | Cell Rep | 2022 | 35594870 | PubTator, text mining | PubMed |
| Serum IL-17A concentration and a IL17RA single nucleotide polymorphism contribute to the risk of autoimmune type 1 diabetes. | Diabetes Metab Res Rev | 2022 | 35583128 | PubTator, text mining | PubMed |
| Molecular and cellular mechanisms of itch and pain in atopic dermatitis and implications for novel therapeutics. | Clin Transl Immunology | 2022 | 35582626 | PubTator, text mining | PubMed |
| IL-17: an important pathogenic factor in endometriosis. | Int J Med Sci | 2022 | 35582411 | PubTator, text mining | PubMed |
| New insights into the immunologic role of oligodendrocyte lineage cells in demyelination diseases. | J Biomed Res | 2022 | 35578762 | PubTator, text mining | PubMed |
| SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. | Front Immunol | 2022 | 35572514 | PubTator, text mining | PubMed |
| The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value. | J Clin Med | 2022 | 35566637 | PubTator, text mining | PubMed |
| Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. | J Clin Med | 2022 | 35566548 | PubTator, text mining | PubMed |
| Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer. | Cells | 2022 | 35563856 | PubTator, text mining | PubMed |
| Skin Inflammation Modulation via TNF-α, IL-17, and IL-12 Family Inhibitors Therapy and Cancer Control in Patients with Psoriasis. | Int J Mol Sci | 2022 | 35563587 | PubTator, text mining | PubMed |
| Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development. | Front Immunol | 2022 | 35558069 | PubTator, text mining | PubMed |
| Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention. | J Crohns Colitis | 2022 | 35553667 | PubTator, text mining | PubMed |
| Blockade of IL-23: What is in the Pipeline? | J Crohns Colitis | 2022 | 35553666 | PubTator, text mining | PubMed |
| Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis. | Mil Med Res | 2022 | 35550651 | PubTator, text mining | PubMed |
| Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L. | BMC Complement Med Ther | 2022 | 35550086 | PubTator, text mining | PubMed |
| Th17 cell-derived miR-155-5p modulates interleukin-17 and suppressor of cytokines signaling 1 expression during the progression of systemic sclerosis. | J Clin Lab Anal | 2022 | 35545753 | PubTator, text mining | PubMed |
| Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia. | Int J Clin Oncol | 2022 | 35536524 | PubTator, text mining | PubMed |
| Biologics for Non-Cancer Dermatological Diseases: Analysis on China's Clinical Trial Registration Trend From 2016 to 2020. | Front Pharmacol | 2022 | 35529441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23765/papers?page=55